Core Viewpoint - The article discusses the significant upgrade of oral semaglutide, which is redefining the competitive landscape in the GLP-1 drug market by enhancing the formulation and delivery system, thus raising the bar for future competitors [2][3][5][7]. Group 1: Product Upgrade - The new formulation of oral semaglutide features optimized dosages of 1.5 mg, 4 mg, and 9 mg, compared to the original 3 mg, 7 mg, and 14 mg, indicating improved absorption efficiency at lower doses [2][3]. - The upgrade is not merely a reduction in dosage but reflects advancements in the formulation design and delivery efficiency, achieving equivalent exposure with lower doses [2][3]. Group 2: Delivery System Challenges - Oral peptide drugs face significant challenges, including degradation in the gastrointestinal environment, destruction by digestive enzymes, and poor permeability through epithelial barriers [3]. - The delivery strategy centered around SNAC has been crucial in enhancing the absorption conditions in the stomach and facilitating effective trans-mucosal penetration, significantly improving the oral bioavailability of semaglutide [3]. Group 3: Competitive Landscape - The complexity of replicating the oral semaglutide delivery system makes it more challenging for generic manufacturers compared to injectable forms, as the core logic of the delivery platform remains difficult to duplicate [5]. - The proactive upgrade of the formulation by the original manufacturer serves as a defensive strategy, enhancing product competitiveness and raising the entry barriers for potential competitors [5][7]. Group 4: Industry Implications - The upgrade of oral semaglutide signals a shift in the peptide drug industry, where the competitive edge increasingly relies on formulation platforms and delivery capabilities rather than just the active molecule itself [7]. - For generic drug companies, the rules of engagement have changed, making it more complex to enter the market, as the focus will now be on achieving convenience, stability, and efficiency in drug delivery [7].